Comparison of the Clinical Effectiveness of Oseltamivir and Zanamivir against Influenza Virus Infection in Children
Clinical Infectious Diseases, Volume 0, Issue 0, Page 000, Latest Articles.
Background.  We compared the clinical effectiveness of oseltamivir and zanamivi....   Full Article

Long‐Term Prognosis of HIV‐Infected Patients with Kaposi Sarcoma Treated with Pegylated Liposomal Doxorubicin
Clinical Infectious Diseases, Volume 0, Issue 0, Page 000, Latest Articles.
Introduction.  Incidence of Kaposi sarcoma (KS) in human immunodeficiency virus....   Full Article

Treatment of Kaposi Sarcoma in the Highly Active Antiretroviral Therapy Era
Clinical Infectious Diseases, Volume 0, Issue 0, Page 000, Latest Articles.
....   Full Article

View All Recent News Articles

In 1995, the CDC granted a Cooperative Agreement Program award to the Infectious Diseases Society of America (IDSA) to develop a provider-based emerging infections sentinel network: the Emerging Infections Network (IDSA EIN).

During the past decade, the IDSA EIN has evolved into a flexible sentinel network composed of over 1,100 infectious disease specialists primarily from North America, with some global members. The overarching goal of the EIN is to assist CDC and other public health authorities with surveillance for emerging infectious diseases and related phenomena.

The specific goals of the EIN are to:

1. detect new or unusual clinical events;
2. identify cases during outbreak investigations;
3. gather information about clinical aspects of emerging infectious diseases;
4. help connect members to the CDC and other public health investigators; and
5. develop new methods for gathering epidemiological and clinical information.